Large-scale mobilization and isolation of CD34+ cells from normal donors.
We describe collection and purification of peripheral blood CD34+ cells from volunteer, normal donors and allogeneic stem cell donors. A total of 98 aphereses were performed on 68 volunteer donors using peripheral venous access. The mean number of nucleated cells collected was 4.6 x 10(10) which included 1.9 x 10(8) CD34+ cells corresponding to 2.7 x 10(6) CD34+ cells/kg. The number of CD34+ cells collected did not differ between males and females but did correlate with the donor's weight and the total number of nucleated cells collected. The Nexell Isolex 300i cell separator was used to isolate CD34+ cells from 30 of the collections. A mean of 0.36% of the total cells was recovered and included 43 +/- 18% of the CD34+ cells. CD34+ cells represented 85 +/- 11% of the recovered cells. The total number of CD34+ cells recovered was not influenced by the number of nucleated cells placed on the Isolex 300i. The percentage of CD34+ cells recovered was not related to the number of CD34+ cells placed on the Isolex 300i. The purity of the final product was influenced by the number of CD34+ cells but not the total number of nucleated cells. An additional 38 CD34+ cell isolations were performed on normal allogeneic stem cell donors with similar results. These observations further support the safety and feasibility of peripheral blood CD34+ cell collection and purification.
Section of Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, IN 46202, USA.
J M
JM
Croop
R
R
Cooper
R
R
Seshadri
C
C
Fernandez
V
V
Graves
S
S
Kreissman
F O
FO
Smith
K
K
Cornetta
D A
DA
Williams
R
R
Abonour
D000328:Adult; D018952:Antigens, CD34 / Q000032:analysis*; D001781:Blood Component Removal / Q000009:adverse effects / Q000295:instrumentation; D001782:Blood Donors; D001835:Body Weight; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects / Q000379:methods / Q000592:standards*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D012737:Sex Factors
D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor